Link to this page
The Drug-Drug Interactions Ontology
Last uploaded:
February 11, 2016
| Id | http://purl.obolibrary.org/obo/CHEBI_68647
http://purl.obolibrary.org/obo/CHEBI_68647
|
|---|---|
| Preferred Name | regorafenib |
| Synonyms |
Regorafenibum
C21H15ClF4N4O3
regorafenib
BAY 73-4506
4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenoxy]-N-methylpyridine-2-carboxamide
regorafenibum
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| prefLabel | regorafenib
|
|---|---|
| label | regorafenib
|
| DBSynonym | bay 73-4506
|
| ATCCode | L01XE21
|
| Definition | Regorafenib is an orally-administered inhibitor of multiple kinases. It is used for the treatment of metastatic colorectal cancer and advanced gastrointestinal stromal tumours. FDA approved on September 27, 2012.
A pyridinecarboxamide obtained by condensation of 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenoxy]pyridine-2-carboxylic acid with methylamine. Used for for the treatment of metastatic colorectal cancer in patients who have previously received chemotherapy, anti-EGFR or anti-VEGF therapy.
|
| has pharmacological target |
See more
See less
|
| inhibits |
See more
See less
|
| type | |
| has role | |
| InChIKey |
InChIKey=FNHKPVJBJVTLMP-UHFFFAOYNA-N
InChIKey=FNHKPVJBJVTLMP-UHFFFAOYSA-N
|
| is metabolised by | |
| AHFScode | 10:00
|
| Synonym | Regorafenibum
C21H15ClF4N4O3
regorafenib
BAY 73-4506
4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenoxy]-N-methylpyridine-2-carboxamide
regorafenibum
See more
See less
|
| xref |
RxList:http://www.rxlist.com/stivarga-drug.htm
CiteXplore:22568966
Patent:WO2008055629
Wikipedia:Regorafenib
Patent:WO2007068380
CASRN:755037-03-7
Reaxys:14359949
CiteXplore:22577890
Patent:WO2008089388
Patent:WO2007068382
CiteXplore:22777740
Patent:WO2008089389
Wikipedia:http://en.wikipedia.org/wiki/Regorafenib
Patent:WO2007054216
CiteXplore:21752724
Patent:WO2006125540
ChEMBL:1377553
Patent:WO2011128261
Patent:WO2008043446
National Drug Code Directory:50419-171-03
CiteXplore:22421192
Patent:US2006058358
CiteXplore:22612461
Patent:WO2011130728
CiteXplore:22959186
KEGG DRUG:D10138
CiteXplore:21419931
ChEBI:68647
CiteXplore:21170960
CiteXplore:22614970
Patent:WO2008058644
CiteXplore:22785409
CiteXplore:22706543
Drugs.com:http://www.drugs.com/cdi/regorafenib.html
See more
See less
|
| CASRN | 755037-03-7
|
| prefixIRI | obo2:CHEBI_68647
|
| SMILES |
CNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1
|
| may interact with |
See more
See less
|
| InChI | InChI=1/C21H15ClF4N4O3/c1-27-19(31)18-10-13(6-7-28-18)33-12-3-5-17(16(23)9-12)30-20(32)29-11-2-4-15(22)14(8-11)21(24,25)26/h2-10H,1H3,(H,27,31)(H2,29,30,32)
InChI=1S/C21H15ClF4N4O3/c1-27-19(31)18-10-13(6-7-28-18)33-12-3-5-17(16(23)9-12)30-20(32)29-11-2-4-15(22)14(8-11)21(24,25)26/h2-10H,1H3,(H,27,31)(H2,29,30,32)
|
| DBBrand | stivarga
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |